Imaging Tumor Metastases with Molecular Probes

Curr Pharm Des. 2015;21(42):6260-4. doi: 10.2174/1381612821666151027153943.

Abstract

Tumor metastasis is an important prognostic factor regarding long-term survival rate of cancer patients. At present, no imaging modality or technique is ideal for diagnosis of metastases. Molecular imaging has provided a fantastic tool for tumor metastases imaging. Based on the current medical imaging tools such as magnetic resonance imaging (MRI), optical, single-photon emission computed tomography (SPECT), and positron emission tomography (PET), various techniques and functional molecular probes for molecular imaging of tumor metastases have been developed. In this review, we will summarize the current status of nanoprobe based molecular imaging metastases in cancer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Magnetic Resonance Imaging / methods
  • Molecular Imaging / methods*
  • Molecular Probes / chemistry
  • Neoplasm Metastasis / diagnosis*
  • Neoplasm Metastasis / pathology
  • Neoplasms / diagnosis*
  • Neoplasms / pathology
  • Positron-Emission Tomography / methods
  • Prognosis
  • Survival Rate
  • Tomography, Emission-Computed, Single-Photon / methods

Substances

  • Molecular Probes